Literature DB >> 21286336

The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

João-Bruno Soares1, Pedro Pimentel-Nunes, Roberto Roncon-Albuquerque, Adelino Leite-Moreira.   

Abstract

Toll-like receptor 4 (TLR4) is a pattern recognition receptor that functions as lipopolysaccharide (LPS) sensor and whose activation results in the production of several pro-inflammatory, antiviral, and anti-bacterial cytokines. TLR4 is expressed in several cells of healthy liver. Despite the constant confrontation of hepatic TLR4 with gut-derived LPS, the normal liver does not show signs of inflammation due to its low expression of TLR4 and ability to modulate TLR4 signaling. Nevertheless, there is accumulating evidence that altered LPS/TLR4 signaling is a key player in the pathogenesis of many chronic liver diseases (CLD). In this review, we first describe TLR4 structure, ligands, and signaling. Later, we review liver expression of TLR4 and discuss the role of LPS/TLR4 signaling in the pathogenesis of CLD such as alcoholic liver disease, nonalcoholic fatty liver disease, chronic hepatitis C, chronic hepatitis B, primary sclerosing cholangitis, primary biliary cirrhosis, hepatic fibrosis, and hepatocarcinoma.

Entities:  

Keywords:  Chronic liver diseases; Lipopolysaccharide; Toll-like receptor 4

Year:  2010        PMID: 21286336      PMCID: PMC2994611          DOI: 10.1007/s12072-010-9219-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  84 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 2.  Non-alcoholic fatty liver disease: lumen-liver interactions and possible role for probiotics.

Authors:  Steven F Solga; A M Diehl
Journal:  J Hepatol       Date:  2003-05       Impact factor: 25.083

3.  Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M.

Authors:  Khalid A Tazi; Jean-Jacques Quioc; Véronique Saada; Annie Bezeaud; Didier Lebrec; Richard Moreau
Journal:  J Hepatol       Date:  2006-03-31       Impact factor: 25.083

4.  Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4.

Authors:  G L Su; R D Klein; A Aminlari; H Y Zhang; L Steinstraesser; W H Alarcon; D G Remick; S C Wang
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

5.  Exacerbation of alcoholic liver injury by enteral endotoxin in rats.

Authors:  P Mathurin; Q G Deng; A Keshavarzian; S Choudhary; E W Holmes; H Tsukamoto
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

6.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

7.  The molecular basis of the host response to lipopolysaccharide.

Authors:  Clare E Bryant; David R Spring; Monique Gangloff; Nicholas J Gay
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

8.  Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta.

Authors:  E Seki; H Tsutsui; H Nakano; N Tsuji; K Hoshino; O Adachi; K Adachi; S Futatsugi; K Kuida; O Takeuchi; H Okamura; J Fujimoto; S Akira; K Nakanishi
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

9.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

10.  Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.

Authors:  Takayuki Abe; Yuuki Kaname; Itsuki Hamamoto; Yoshimi Tsuda; Xiaoyu Wen; Shuhei Taguwa; Kohji Moriishi; Osamu Takeuchi; Taro Kawai; Tatsuya Kanto; Norio Hayashi; Shizuo Akira; Yoshiharu Matsuura
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

View more
  83 in total

Review 1.  Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis.

Authors:  Alexander Wree; Wajahat Z Mehal; Ariel E Feldstein
Journal:  Semin Liver Dis       Date:  2016-02-12       Impact factor: 6.115

2.  Mesenchymal stem cells cannot affect mRNA expression of toll-like receptors in different tissues during sepsis.

Authors:  Leonardo Pedrazza; Talita Carneiro Brandão Pereira; Ana Lucia Abujamra; Fernanda Bordignon Nunes; Maurício Reis Bogo; Jarbas Rodrigues de Oliveira
Journal:  Inflamm Res       Date:  2017-04-08       Impact factor: 4.575

Review 3.  Signal transductions and nonalcoholic fatty liver: a mini-review.

Authors:  Lu Zeng; Wai J Tang; Jin J Yin; Bei J Zhou
Journal:  Int J Clin Exp Med       Date:  2014-07-15

4.  The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury.

Authors:  Saravanakumar Selvaraj; Jung-Hwa Oh; Reinhard Spanel; Florian Länger; Hyoung-Yun Han; Eun-Hee Lee; Seokjoo Yoon; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-09-23

5.  Mild Innate Immune Activation Overrides Efficient Nanoparticle-Mediated RNA Delivery.

Authors:  Melissa P Lokugamage; Zubao Gan; Chiara Zurla; Joel Levin; Fatima Z Islam; Sujay Kalathoor; Manaka Sato; Cory D Sago; Philip J Santangelo; James E Dahlman
Journal:  Adv Mater       Date:  2019-11-19       Impact factor: 30.849

6.  Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes.

Authors:  Arvin Iracheta-Vellve; Jan Petrasek; Benedek Gyongyosi; Abhishek Satishchandran; Patrick Lowe; Karen Kodys; Donna Catalano; Charles D Calenda; Evelyn A Kurt-Jones; Katherine A Fitzgerald; Gyongyi Szabo
Journal:  J Biol Chem       Date:  2016-11-03       Impact factor: 5.157

Review 7.  Nonalcoholic Fatty Liver Disease, the Gut Microbiome, and Diet.

Authors:  Zeinab Mokhtari; Deanna L Gibson; Azita Hekmatdoost
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

8.  Blood-Borne Lipopolysaccharide Is Rapidly Eliminated by Liver Sinusoidal Endothelial Cells via High-Density Lipoprotein.

Authors:  Zhili Yao; Jessica M Mates; Alana M Cheplowitz; Lindsay P Hammer; Andrei Maiseyeu; Gary S Phillips; Mark D Wewers; Murugesan V S Rajaram; John M Robinson; Clark L Anderson; Latha P Ganesan
Journal:  J Immunol       Date:  2016-08-17       Impact factor: 5.422

Review 9.  Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease.

Authors:  Elise Slevin; Leonardo Baiocchi; Nan Wu; Burcin Ekser; Keisaku Sato; Emily Lin; Ludovica Ceci; Lixian Chen; Sugeily R Lorenzo; Wenjuan Xu; Konstantina Kyritsi; Victoria Meadows; Tianhao Zhou; Debiyoti Kundu; Yuyan Han; Lindsey Kennedy; Shannon Glaser; Heather Francis; Gianfranco Alpini; Fanyin Meng
Journal:  Am J Pathol       Date:  2020-09-11       Impact factor: 4.307

10.  Donor polymorphisms of toll-like receptor 4 associated with graft failure in liver transplant recipients.

Authors:  William S Oetting; Weihua Guan; David P Schladt; Robert E Leduc; Pamala A Jacobson; Arthur J Matas; Srinath Chinnakotla; Bernd Schröppel; Barbara T Murphy; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-12       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.